
### [NCIT:C7472](http://purl.obolibrary.org/obo/NCIT_C7472)
**Label:** Anal Margin Carcinoma

**Subclasses:** [NCIT:C6925](http://purl.obolibrary.org/obo/NCIT_C6925) (Anal Margin Squamous Cell Carcinoma), [NCIT:C7476](http://purl.obolibrary.org/obo/NCIT_C7476) (Paget Disease of the Anal Margin), [NCIT:C7473](http://purl.obolibrary.org/obo/NCIT_C7473) (Anal Margin Basal Cell Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.10%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39152](http://purl.obolibrary.org/obo/NCIT_C39152) (Hepatocyte Growth Factor Receptor Signaling Pathway BioCarta))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39147](http://purl.obolibrary.org/obo/NCIT_C39147) (Calpain-2 Cell Motility Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39146](http://purl.obolibrary.org/obo/NCIT_C39146) (MAPKinase Signaling Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39141](http://purl.obolibrary.org/obo/NCIT_C39141) (Longevity Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39135](http://purl.obolibrary.org/obo/NCIT_C39135) (Keratinocyte Differentiation Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39130](http://purl.obolibrary.org/obo/NCIT_C39130) (Insulin Signaling Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39128](http://purl.obolibrary.org/obo/NCIT_C39128) (IL7 Signaling Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39124](http://purl.obolibrary.org/obo/NCIT_C39124) (IL3 Signaling Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39123](http://purl.obolibrary.org/obo/NCIT_C39123) (IL2RB Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 38.69%


